An Open Label Study To Evaluate The Safety and Pharmacokinetics of Nelfinavir in HIV / Hepatitis C (HCV) Co-Infected Subjects With Hepatic Dysfunction.

Trial Profile

An Open Label Study To Evaluate The Safety and Pharmacokinetics of Nelfinavir in HIV / Hepatitis C (HCV) Co-Infected Subjects With Hepatic Dysfunction.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2011

At a glance

  • Drugs Nelfinavir (Primary)
  • Indications Hepatitis C; HIV infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 22 Oct 2007 Status changed from in progress to completed.
    • 01 Nov 2006 Status changed from recruiting to in progress.
    • 08 Dec 2005 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top